News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,086 Results
Type
Article (39155)
Company Profile (284)
Press Release (648647)
Section
Business (203912)
Career Advice (1996)
Deals (35376)
Drug Delivery (89)
Drug Development (80857)
Employer Resources (168)
FDA (16099)
Job Trends (14810)
News (344665)
Policy (32451)
Tag
Academia (2531)
Alliances (49192)
Alzheimer's disease (1262)
Approvals (16061)
Artificial intelligence (145)
Bankruptcy (352)
Best Places to Work (11582)
Biotechnology (201)
Breast cancer (190)
Cancer (1377)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (282)
Clinical research (64717)
Collaboration (485)
Compensation (264)
COVID-19 (2542)
C-suite (109)
Data (1395)
Diabetes (177)
Diagnostics (6171)
Earnings (84895)
Employer resources (146)
Events (110022)
Executive appointments (397)
FDA (16786)
Funding (432)
Gene therapy (195)
GLP-1 (599)
Government (4333)
Healthcare (18697)
Infectious disease (2635)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16346)
Job creations (3627)
Job search strategy (1418)
Layoffs (418)
Legal (7864)
Lung cancer (198)
Manufacturing (207)
Medical device (13214)
Medtech (13219)
Mergers & acquisitions (19201)
Metabolic disorders (461)
Neuroscience (1585)
NextGen Class of 2024 (6501)
Non-profit (4467)
Northern California (1703)
Obesity (262)
Opinion (183)
Parkinson's disease (98)
Patents (121)
People (56466)
Phase I (20131)
Phase II (28500)
Phase III (21244)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (264)
Real estate (5894)
Regulatory (21683)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1471)
Startups (3562)
United States (15256)
Vaccines (564)
Weight loss (182)
Date
Today (3)
Last 7 days (381)
Last 30 days (2284)
Last 365 days (35290)
2024 (35164)
2023 (40076)
2022 (51175)
2021 (55713)
2020 (54088)
2019 (46543)
2018 (35020)
2017 (32112)
2016 (31483)
2015 (37553)
2014 (31319)
2013 (26348)
2012 (28571)
2011 (29266)
2010 (27328)
Location
Africa (713)
Arizona (196)
Asia (37282)
Australia (6088)
California (3837)
Canada (1461)
China (309)
Colorado (173)
Connecticut (178)
Europe (79849)
Florida (538)
Georgia (136)
Illinois (387)
Indiana (225)
Maryland (635)
Massachusetts (2977)
Michigan (175)
Minnesota (292)
New Jersey (1108)
New York (1094)
North Carolina (743)
Northern California (1703)
Ohio (146)
Pennsylvania (930)
South America (1092)
Southern California (1471)
Texas (555)
Utah (108)
Washington State (401)
688,086 Results for "cognate bioservices inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance
Avid Bioservices, Inc. announced that the company has achieved a Committed Badge from EcoVadis, one of the world’s most trusted providers of business sustainability ratings.
May 23, 2024
·
2 min read
Press Releases
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024
December 10, 2024
·
9 min read
Biotech Beach
Avid Bioservices to Participate at Upcoming May 2024 Investor Conferences
Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, announced that the company will participate at two upcoming investor conferences.
May 7, 2024
·
1 min read
Press Releases
Cellipont Bioservices and Xiogenix Announce Strategic Partnership to Enhance Client Access to Advanced Filling Systems
December 10, 2024
·
3 min read
Press Releases
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024
Avid Bioservices, Inc. today announced that it will report financial results for the quarter and fiscal year ended April 30, 2024, on July 2, 2024, after market close and will host a webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time).
July 1, 2024
·
1 min read
Business
Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference
September 12, 2024
·
1 min read
Biotech Beach
Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization, announced the pricing of $160 million aggregate principal amount of 7.00% Convertible Senior Notes due 2029.
March 7, 2024
·
5 min read
Business
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced financial results for the third quarter and nine months ended January 31, 2024.
April 24, 2024
·
18 min read
Business
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
Avid Bioservices, Inc. (NASDAQ:CDMO) today announced preliminary earnings estimates for the third quarter and nine months ended January 31, 2024.
March 6, 2024
·
7 min read
Press Releases
Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction
November 7, 2024
·
11 min read
1 of 68,809
Next
